Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...

A fundraiser has been set up for a University of South Wales graduate who’s been diagnosed with a rare and aggressive cancer ...

Get Anti-cancer drug Toripalimab News on Telangana Today, Anti-cancer drug Toripalimab latest news, Anti-cancer drug Toripalimab news, | Telangana Today ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Dr Reddy's Laboratories has launched Toripalimab, a groundbreaking drug for treating recurrent or metastatic nasopharyngeal carcinoma (NPC) in India. The drug, marketed as Zytorvi, addresses an unmet ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A NEW mum has tragically died from cancer after being given a heartbreaking choice to either save her own life or her unborn ...

Jeffs' Brands and Deliverz.AI Sign a Binding Letter of Intent for a U.S. Joint Venture Involving AI-Powered Fully Autonomous ...